ASEP's diagnostic and therapeutic applications $ASEP.c is trading at quite an attractive valuation right now given it's located in a market full of unmet needs.
As ASEP offers a rapid way to identify sepsis as well as treat it, they are positioned to win a meaningful share in the market. Their diagnostic application has a clear and easy path to generate revenue, which is notable given its commercialization is expected in mid-2022. Plus, ASEP's therapeutic product is expected to be fast-tracked to clinical trials within the next year as well.
https://asepmedical.com/investors/